Study Examines Dementia Caregiver Experiences and Preparedness
As the global population ages, people providing care for more than one family member or close other across adulthood is becoming increasingly common. Yet little is known about the ways prior caregiving experiences shape an individual’s future preparedness when it comes to caring for additional people living with dementia.
Yale School of Public Health joins CDC-funded Pathogen Genomics Center of Excellence
The Massachusetts Department of Public Health has selected the Yale School of Public Health (YSPH) and six other partners to make up its new Pathogen Genomics Center of Excellence, one of five such centers recently launched by the U.S. Centers for Disease Control and Prevention. With $25 million in funding over five years, the center’s goal will be to improve technologies and coordinated processes for systematically monitoring infectious diseases and emerging variants, enabling the U.S. to better prevent and respond to outbreaks.
Nathan Grubaugh honored with prestigious NIH New Innovator award
Yale School of Public Health Associate Professor Nathan Grubaugh has received a prestigious New Innovator Award from the National Institutes of Health in recognition of his potentially transformative biomedical research as a young career investigator.
Yale Biostatistician Heping Zhang Delivers Prestigious Neyman Lecture
Heping Zhang, the Susan Dwight Bliss Professor of Biostatistics at the Yale School of Public Health, recently delivered the prestigious 2022 Neyman Memorial Lecture presented by the Institute of Mathematical Statistics (IMS) – one of the highest honors in statistical societies.
Yale Geneticist With Rare Disease to Build Pediatric Cell Atlas of Skeletal Muscle
A $3 million grant from the Chan Zuckerberg Initiative, awarded to a team of researchers led by Monkol Lek, PhD, assistant professor of genetics at Yale, will support Lek and his team in creating a Pediatric Cell Atlas of Skeletal Muscle — a roadmap of healthy skeletal cells and how they change at four key age group milestones between the ages of zero and 18 years.
Strategies to accelerate diagnosis and treatment of rare cardiovascular diseases
The current landscape for patients with rare cardiovascular disease has shifted. Using genome sequencing Yale physician-scientists have begun to elucidate the pathophysiology of genetic disorders and develop treatment guidelines and recommendations.